ContributorsMarschall S. Runge, Charles S. Ebert, M. Andrew Greganti et al.|Elsevier eBooks|2009Cited by 0
ContributeursMarschall S. Runge, Charles S. Ebert, M. Andrew Greganti et al.|Elsevier eBooks|2011Cited by 0
648 A pilot study to evaluate the combination of zimberelimab, domvanalimab and etrumadenant in patients with previously treated non-small cell lung cancer (NSCLC)Anjali Rohatgi, Daniel Morgensztern, Siddhartha Devarakonda et al.|Regular and Young Investigator Award Abstracts|2025Cited by 0